Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry & Director of the BioSpectroscopy Core Research Laboratory at Faculty of Chemistry, California South University (CSU), Irvine, California, USA & President of American International Standards Institute (AISI) Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic–scientific–research institutes around the world.
His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc.
Giulio Tarro graduated from Medicine School, Naples University (1962), Italy. Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus (2006). Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President, Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Virology, Oncology, Immunology and Microbiology
Yoshinori HAYAKAWA has graduated from Tokyo University, Department of Applied Physics. He received Ph.D. in Tokyo Institute of Technology. He then engaged in Boron-Neutron-Therapy in Teikyo University and then Proton Radiation Beam Therapy in University of Tsukuba. He has Measured, first in the world, acoustic pulse generated in the patient’s body treated by pulsed proton beam. The phenomenon will be used to monitor dose distribution in patients as planed or not. He then become a professor in Toin University of Yokohama. He is now retired. He is interested in researches on wellbeing of human life. He has developed Computer Numerals and New Abacus Numerals for improving basic education to reduce poverty. He has developed Universal Literacy Alphabet as well. He is now developing a plan to eliminate glacial period by reflecting sun light by mirrors on the moon surface and Lagrangian points of moon orbit.
Health Information Management, Medical and Health Sciences
Dr. Tamer Mohamed is an Assistant Professor at the University of Louisville, USA. He has completed his Ph.D. at the age of 30 from University of Manchester, UK. Then, He did his post-doctoral training at the J. David Gladstone Research Institute (UCSF, CA, USA) to identify novel therapies for heart failure. He has published more than 25 papers in reputed international journals with the most recent publication in CELL and has been awarded several awards including the prestigious Young Investigator Award at the European Society of Cardiology Congress in 2010 and the Arnold Katz award at the American Heart Association 2017.
Cardiology, Pharmacology, Drug Development, Clinical Trails, Stem Cell Technology, Genomics.
Dr. Carolle-Laure KPOUMIE has worked as pediatric assistant physician in pediatric’s department of faculty of medicine in Cameroon, as clinical researcher methodology, scientific writing, public health, oncology, internal medicine and continued her career in pharmaceutical industries in France. She participates in many congress with studies made in hospitals on relevant cases in the framework Studies and clinical research. She became head of department, director, head of district where she continued her research, writing of treatment protocols in different departments for common pathologies encountered in her context, managing Epidemic crisis such as cholera, meningitis, avian influenza, yellow fever and organizes campaigns on infectious diseases ,HIV, cardiovascular diseases, family planning, research on severe malaria, malnutrition in Children and participates in studies on neonatal mortality in underdeveloped countries. She work on ADR in hospital following drug administration, pharmacovigilance, vaccinovigilance, biovigilance, materiovigilance in underdeveloped countries, articles, medical information and therapeutic safety, clinical trials, Post-marketing, and other’s studies.
Clinical Reserach, Pharmacology & Toxicology, Pharmacovigilance,Internal medecine, Rare Deseases, Oncology, Haematology,Endocrinology, Antiviral therapy and Neuropsychiatry
Dr.William “Bill” Rudman, currently serves as the Executive Director of the Interprofessional Healthcare Workforce Institute Rosalind Franklin University of Medicine and Science. Before moving to Rosalind Franklin Dr. Rudman, served as the Executive Director of the AHIMA Foundation and Vice President of Education Visioning for the American Health Information Management Association (AHIMA). Rudman worked for over 20 years in Academia as a Professor in health information management.Rudman also served as the director of the HIT core for the Delta Regional Institute and oversaw implementation of an electronic record exchange in rural Mississippi; and was the PI on the HISPC grant for education and training for the implementation on electronic medical records for the state of Tennessee. Rudman has published over 80 scholarly articles, made 170 scholarly presentations, and has worked on and received over $80 million in federally funded grants.
Health Information Management, Medical and Health Sciences
Keith J. Simons joined the Faculty of Pharmacy, University of Manitoba in 1975 as an Assistant Professor. He was promoted to Full Professor in 1986, with adjunct appointments in the Faculty of Science and the Faculty of Medicine. He was Head of the Division of Pharmaceutical Sciences from 1994-2004, and Associate Dean, Research from 2004 to 2009. During a career spanning more than three decades, he developed and taught undergraduate and graduate courses in physical pharmacy, pharmaceutics, dispensing and non-prescription drugs, and pharmacokinetics. He has contributed to the education of more than 1,200 pharmacists, most of who practiced or are currently practicing in the province of Manitoba. He has mentored many MSc and PhD students. His research work resulted in more than 360 publications During his long career, Dr. Simons served on and chaired most of the Faculty of Pharmacy standing committees, most recently various Faculty of Graduate Studies committees. He is an active member of a number of pharmaceutical and medical associations in Canada and the United States. He served as a Council Member (1976-1985) and as President (1986-1987) of the Association of Faculties of Pharmacy of Canada, as an examiner (1976-1988) on the Pharmacy Examining Board of Canada, and as the elected representative of the academic pharmacists on the Canadian Pharmacists Association Board of Directors (1991-2002). In November 2013 he was awarded the first Leslie F. Buggey Professorship in the Faculty of Pharmacy.
Pharmaceutics, Pharmacokinetics and Pharmacodynamics, Allergy & Clinical Immunology, Clinical Research
Hyun-soon Chong has completed her Ph.D. from the University of North Texas and her research involves organic synthesis, medicinal chemistry, synthetic methodology development, bioconjugate chemistry, bioanalytical chemistry, bioinorganic chemistry, biochemistry, and antibody drug conjugate chemistry. Chong’s current research interest focuses on interdisciplinary research projects aimed at developing safe, effective, and targeted drugs for cancer and neurodegenerative diseases including small molecule inhibitors, bioconjugates, and nuclear medicine. Her team has developed several promising cancer therapeutic and imaging agents with successful preclinical profiles that are favorably compared to the existing anti-cancer drugs and radiopharmaceuticals. The Chong’s team is specialized in chemistry of aziridinium ions as versatile and reactive intermediate compounds in organic synthesis of enantiomerically enriched molecules. Her team has conducted synthetic and mechanistic studies of the strained and labile aziridinium ions and utilized aziridinium ion chemistry for development of biologically active molecules and macrocyclic and acyclic chelating agents for biomedical and environmental health applications. Disciplines of Chemistry, Medicinal Chemistry, Oncology, Neurodegenerative Diseases, Drug Development, Drug Delivery, Clinical Research and Nuclear medicine
Disciplines of Chemistry, Medicinal Chemistry, Oncology, Neurodegenerative Diseases, Drug Development, Drug Delivery, Clinical Research and Nuclear medicine
Dr.Jorge I. González Borroto is a Toxicologist with more than 15 years of expertise in the field of Toxicology, Pharmacovigilance and Drug safety assessment. He has worked for many Pharma Companies and Contract Research Organizations. He is currently working as a Senior Toxicologist, involved in Pharmacovigilance to support the efficacy, safety and well-use of medicines, in Ferrer Internacional, Barcelona, Spain. He is also the director of in vitro and in vivo toxicological studies in drug development and drug-candidate selection. He has more than 10 years of Experience in toxicological data interpretation, preparation of nonclinical toxicology-safety report, reviews and summaries of safety of new drugs to support clinical studies, predictive toxicology, Set up and validation of novel test and cell-based assays in drug discovery. He is also the Reviewer of the Journals of Toxicology and Editorial Board Member of several scientific journals and Organizing Committee Member of several Scientific events. He has involved in the European Commission as an expert for the Sixth and Seventh Framework Programme in the area Preclinical Toxicology and Mutagenesis as well.
Toxicology, Safety Assessment, Pharmacovigilance, Quality Control, Clinical Research, Safety Pharmacology, Toxicokinetic, Bioanalysis, Drug Development